Essais liés2clinical trials
VilleAnderlechtlocalisation
PaysBelgiumlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06132893

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
BHV-7000 Épilepsie Phase 2/3 NCT06132893 RISE 2 — A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy RECRUITING
Efgartigimod IV Myasthénie Phase 3 NCT06298552 ADAPT SERON — A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis ACTIVE_NOT_RECRUITING